Tech Company Financing Transactions

Carmell Therapeutics Funding Round

Carmell Therapeutics, operating out of Pittsburgh, raised $3 million in funding from Harbor Light Capital Partners, BlueTree Allied Angels and Innovation Works.

Transaction Overview

Announced On
4/15/2011
Transaction Type
Debt
Venture Equity
Amount
$3,000,000
Round
Series A
Proceeds Purpose
The company will use the financing to establish a pilot manufacturing facility and collect data for early clinical validation for the company's first products.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 300
Pittsburgh, PA 15203
USA
Email Address
Overview
Carmell Therapeutics is a biotechnology company focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs). These PBMs contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
Profile
Carmell Therapeutics LinkedIn Company Profile
Social Media
Carmell Therapeutics Company Twitter Account
Company News
Carmell Therapeutics News
Facebook
Carmell Therapeutics on Facebook
YouTube
Carmell Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Randy Hubbell
  Randy Hubbell LinkedIn Profile  Randy Hubbell Twitter Account  Randy Hubbell News  Randy Hubbell on Facebook
Chief Medical Officer
James Hart
  James Hart LinkedIn Profile  James Hart Twitter Account  James Hart News  James Hart on Facebook
VP - Client Services
Janet Vargo
  Janet Vargo LinkedIn Profile  Janet Vargo Twitter Account  Janet Vargo News  Janet Vargo on Facebook
VP - R & D
Stephanie Kladakis
  Stephanie Kladakis LinkedIn Profile  Stephanie Kladakis Twitter Account  Stephanie Kladakis News  Stephanie Kladakis on Facebook
VP - Regulatory Affairs
Toby Silverman
  Toby Silverman LinkedIn Profile  Toby Silverman Twitter Account  Toby Silverman News  Toby Silverman on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/15/2011: INVIDI Technologies venture capital transaction
Next: 4/15/2011: Instructure venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary